366 related articles for article (PubMed ID: 33782099)
21. LncRNA MNX1-AS1 sustains inactivation of Hippo pathway through a positive feedback loop with USP16/IGF2BP3 axis in gallbladder cancer.
Liu S; Li H; Zhu Y; Ma X; Shao Z; Yang Z; Cai C; Wu Z; Li M; Gong W; Wu X
Cancer Lett; 2022 Oct; 547():215862. PubMed ID: 35953000
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA ZNFX1-AS1 promotes the tumor progression and metastasis of colorectal cancer by acting as a competing endogenous RNA of miR-144 to regulate EZH2 expression.
Shi L; Hong X; Ba L; He X; Xiong Y; Ding Q; Yang S; Peng G
Cell Death Dis; 2019 Feb; 10(3):150. PubMed ID: 30770796
[TBL] [Abstract][Full Text] [Related]
23. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis.
Chu J; Li H; Xing Y; Jia J; Sheng J; Yang L; Sun K; Qu Y; Zhang Y; Yin H; Wan J; He F
Biomed Pharmacother; 2019 Aug; 116():109029. PubMed ID: 31170665
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA ABHD11-AS1 promotes colorectal cancer progression and invasion through targeting the integrin subunit alpha 5/focal adhesion kinase/phosphoinositide 3 kinase/Akt signaling pathway.
Luo J; Jiang Y; Wu L; Zhuo D; Zhang S; Jiang X; Sun Y; Huang Y
Aging (Albany NY); 2021 Aug; 13(16):20179-20191. PubMed ID: 34375304
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA MNX1-AS1 overexpression promotes the invasion and metastasis of gastric cancer through repressing CDKN1A.
Ma JX; Yang YL; He XY; Pan XM; Wang Z; Qian YW
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4756-4762. PubMed ID: 31210302
[TBL] [Abstract][Full Text] [Related]
26. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
27. Long Noncoding RNA CTD-2245E15.3 Promotes Anabolic Enzymes ACC1 and PC to Support Non-Small Cell Lung Cancer Growth.
Wang C; Meng X; Zhou Y; Yu J; Li Q; Liao Z; Gu Y; Han J; Linghu S; Jiao Z; Wang T; Zhang CY; Chen X
Cancer Res; 2021 Jul; 81(13):3509-3524. PubMed ID: 33941610
[TBL] [Abstract][Full Text] [Related]
28. MNX1-AS1, a c-Myc induced lncRNA, promotes the Warburg effect by regulating PKM2 nuclear translocation.
Wu Y; Wang Y; Yao H; Li H; Meng F; Li Q; Lin X; Liu L
J Exp Clin Cancer Res; 2022 Dec; 41(1):337. PubMed ID: 36476366
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA MNX1-AS1 promotes hepatocellular carcinoma proliferation and invasion through targeting miR-218-5p/COMMD8 axis.
Ji D; Wang Y; Sun B; Yang J; Luo X
Biochem Biophys Res Commun; 2019 Jun; 513(3):669-674. PubMed ID: 30982576
[TBL] [Abstract][Full Text] [Related]
30. LncRNA MNX1-AS1: A novel oncogenic propellant in cancers.
Li T; Zhou S; Yang Y; Xu Y; Gong X; Cheng Y; Wang Y
Biomed Pharmacother; 2022 May; 149():112801. PubMed ID: 35290890
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
33. Prognostic potential of MNX1-AS1 in chemotherapy of colorectal carcinoma.
Zhong G; Zhou M; Wang Z; Zhu W
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):243-247. PubMed ID: 38279423
[TBL] [Abstract][Full Text] [Related]
34. LncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression.
Li Z; Pan C; Wang Z; Deng X; Zhu Q; Wu W; Chen L
Carcinogenesis; 2021 Jul; 42(7):931-939. PubMed ID: 34107009
[TBL] [Abstract][Full Text] [Related]
35. lncRNA ZNF667-AS1 (NR_036521.1) inhibits the progression of colorectal cancer via regulating ANK2/JAK2 expression.
Zhuang L; Ding W; Ding W; Zhang Q; Xu X; Xi D
J Cell Physiol; 2021 Mar; 236(3):2178-2193. PubMed ID: 32853419
[TBL] [Abstract][Full Text] [Related]
36. Activation of MYO1G by lncRNA MNX1-AS1 Drives the Progression in Lung Cancer.
Lv D; Wang Y; Li S; Shao X; Jin Q
Mol Biotechnol; 2023 Jan; 65(1):72-83. PubMed ID: 35819746
[TBL] [Abstract][Full Text] [Related]
37. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
[TBL] [Abstract][Full Text] [Related]
38. The lncRNA FEZF1-AS1 Promotes the Progression of Colorectal Cancer Through Regulating OTX1 and Targeting miR-30a-5p.
Li J; Zhao LM; Zhang C; Li M; Gao B; Hu XH; Cao J; Wang GY
Oncol Res; 2020 Feb; 28(1):51-63. PubMed ID: 31270006
[TBL] [Abstract][Full Text] [Related]
39. SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF.
Saeinasab M; Bahrami AR; González J; Marchese FP; Martinez D; Mowla SJ; Matin MM; Huarte M
J Exp Clin Cancer Res; 2019 Apr; 38(1):172. PubMed ID: 31014355
[TBL] [Abstract][Full Text] [Related]
40. Upregulated long noncoding RNAs LINC02163 and FEZF1-AS1 exert oncogenic roles in colorectal cancer.
Tian Y; Zhou J; Zou Y; Luo B; Liu Q; Cao X
Anticancer Drugs; 2021 Jan; 32(1):66-73. PubMed ID: 32932277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
